PDB112 - TREATMENT AND DOSING PATTERNS AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) INITIATING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) IN SEVERAL COUNTRIES
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.817
https://www.valueinhealthjournal.com/article/S1098-3015(18)34117-2/fulltext
Title :
PDB112 - TREATMENT AND DOSING PATTERNS AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) INITIATING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) IN SEVERAL COUNTRIES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34117-2&doi=10.1016/j.jval.2018.09.817
First page :
Section Title :
Open access? :
No
Section Order :
217